Furthermore, hepatic fibrosis is the most important prognostic factor in NAFLD/NASH [50]; in this study, as shown in Supplementary Table 2, CD8+ PD1+ T cells were associated with liver fibrosis, not CD4+ PD1+ T cells. Here, CD4 is linked to metabolic dysfunction-associated steatohepatitis.